Fig. 5
From: A novel pThr217 tau monoclonal antibody reveals neuropathological heterogeneity in tauopathies

Immunohistochemical labelling of PSP and CBD neuropathology. Immunohistochemical staining was performed as described in the “Materials and methods”. (a) Staining of PSP and CBD striatal tissue using monoclonal antibodies 7F2, AT180, and 1F10 is shown. Scale bar is 80 μm. (b) Semi-quantitative analysis of PSP and CBD tau pathology in the caudate and putamen is described in the “Materials and methods”. Data is presented as mean +/- SEM.